Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 8/Signature 2

From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2025-1-4

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 5: Figure S5

Description: Differentially abundant taxa between the TB and TB + HRZ groups at 2months HR therapy.

Abundance in Group 1: decreased abundance in TB +HRZ group - 2months into HR therapy(W12)

NCBI Quality ControlLinks
Acetivibrio
Acidaminobacter
Alkaliphilus
Anaerovorax
Arthrobacter
Bacteroides
Butyricicoccus
Clostridium
Dorea
Dysgonomonas
Gordonibacter
Hespellia
Mitsuokella
Pediococcus
Peptococcus
Robinsoniella
Romboutsia
Roseburia
Sporobacter
Stomatobaculum
Turicibacter
Tyzzerella
Coprobacter

Revision editor(s): KateRasheed